文献速递关节外科

假体周围感染及其成功治疗对患者报告的生活质量影响有多大?

How Much Does Prosthetic Joint Infection and Its Successful Treatment Affect Patient-reported Quality of Life?
PubMed 文献 · Clin Orthop Relat Res · 2024-10-25

PIANO前瞻性多中心队列研究纳入783例新诊断假体周围感染(PJI)患者,随访2年。基线SF-12v2躯体成分评分中位数37,12个月升至41但仍低于年龄匹配人群常模,且12至24个月无进一步改善;仅40%患者在12个月达到良好功能结局。调整其他因素后,PJI治疗成功使良好功能结局的比值增加67%(95%CI 11%至154%;p=0.02)。

要点

  • PJI患者基线躯体成分评分中位数37,12个月升至41,均低于年龄匹配人群常模。
  • 12至24个月躯体成分评分无进一步改善,PJI对生活质量的影响持续至少2年。
  • 治疗成功使12个月良好功能结局的比值增加67%(95%CI 11%至154%;p=0.02)。

核心结论

  • PJI在基线时对SF-12v2生活质量量表的躯体成分评分有很大影响,且该影响持续至少2年。
  • PJI的成功治疗增加获得良好功能结局的可能性。
  • 这些数据可用于为PJI患者设定预期,并可为未来将生活质量指标纳入临床终点的临床研究提供信息。

研究设计与样本

  • PIANO(澳大利亚和新西兰假体周围感染观察性研究)队列为前瞻性、纵向、多中心队列研究,纳入783例新诊断PJI患者,于2014年7月至2017年12月间在27个中心招募,所有参与者随访2年。
  • SF-12v2评分在诊断时(基线)及诊断后3、12、24个月采集。
  • 治疗成功定义为存活且无临床或微生物学感染证据,且未因指标关节持续使用抗生素。
  • 排除死亡6.6%(52例)、髋膝关节以外部位PJI 4.2%(33例)及数据集不完整者(200例[25.5%])后,498例患者有完整SF-12v2数据集。
  • 证据等级:II级,治疗性研究。

主要发现

  • 基线时躯体成分评分中位数(IQR)为37(30至46),12个月升至41(34至49;p<0.001)。
  • 基线和12个月躯体成分评分均低于年龄匹配普通人群常模。
  • 12至24个月躯体成分评分无进一步改善。
  • 基线时心理成分评分中位数(IQR)为48(37至57),与年龄调整人群常模相似。
  • 仅40%的PJI患者在12个月达到良好功能结局。

关键数值与推荐

  • 良好功能结局定义为12个月时SF-12v2躯体成分评分>50(即高于年龄调整人群均值)或较基线增加≥8.9分。
  • 治疗成功定义为存活且无临床或微生物学感染证据,且未因指标关节持续使用抗生素。

临床怎么用

  • 原文结论指出这些数据可用于为PJI患者设定预期,并可为未来将生活质量指标纳入临床终点的临床研究提供信息。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Uncomplicated joint replacement improves pain and other patient-reported outcome measures (PROMs) such as joint function scores and quality-of-life measures. However, the overall impact of periprosthetic joint infection (PJI) and its successful treatment on PROMs is poorly defined. In this study, we describe quality-of-life scores using the 12-item Short Form survey, version 2 (SF-12v2), collected as part of a large, prospective, observational study of PJI. QUESTIONS/PURPOSES: (1) Do patients with newly diagnosed PJI have lower quality-of-life scores than the general age-matched population? (2) Are lower quality-of-life scores for patients with PJI sustained for ≥ 12 months? (3) What factors are associated with a good functional outcome at 12 months, defined by achieving a physical component summary (PCS) score of > 50 on the SF-12v2 (that is, above the age-adjusted population mean) or an increase of > 8.9 or more from baseline? METHODS: The PIANO (Prosthetic joint Infection in Australia and New Zealand, Observational study) cohort was a prospective, longitudinal, multicenter cohort study of 783 patients with newly diagnosed PJI recruited across 27 centers between July 2014 and December 2017. All participants were followed for 2 years. SF-12v2 scores were collected at diagnosis (baseline) and 3, 12, and 24 months after diagnosis. Treatment success was defined as being alive with no clinical or microbiological evidence of infection and no ongoing use of antibiotics for the index joint. RESULTS: After exclusion of 6.6% (52) who had died, 4.2% (33) with PJI of joints other than hips and knees, and those with incomplete data sets (200 [25.5%]), 498 patients had complete SF-12v2 data sets available. At baseline, the median (IQR) PCS score was 37 (30 to 46), which increased to 41 (34 to 49; p < 0.001) at 12 months. Both measures were lower than those for the general age-matched population norm. There was no further improvement in PCS scores between 12 and 24 months. By contrast, the median (IQR) mental component summary score of the SF-12v2 was similar to age-adjusted population norms (48 [37 to 57]) at baseline. Only 40% of patients with PJI achieved a good functional outcome at 12 months. After adjustment for other factors, treatment success of PJI increased the odds of a good functional outcome by 67% (95% CI 11% to 154%; p = 0.02). CONCLUSION: PJIs have a large effect on the PCS score of the SF-12v2 quality-of-life measure at baseline, which is sustained for at least 2 years. Successful treatment of PJI increases the likelihood of a good functional outcome. These data can be used to set expectations for patients presenting with PJI and can be used to inform future clinical studies in which quality-of-life measures are incorporated into clinical endpoints. LEVEL OF EVIDENCE: Level II, therapeutic study.

来源:Clin Orthop Relat Res,查看原文。版权归原作者所有。

引用

  1. Cooper D, Athan E, Yates P, et al. How Much Does Prosthetic Joint Infection and Its Successful Treatment Affect Patient-reported Quality of Life? Clin Orthop Relat Res. 2024. PMID: 39466405. doi:10.1097/CORR.0000000000003201

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。